is also excited by the possibilities these new insights into EBV’s role raise for developing new treatments. “The virus is smart,” he says. “It hides in B-cells, so targeting it using a ...

Without EBNA1, EBV cannot live in B cells, and MS patients have higher levels of antibodies towards EBNA1. But EBV makes over 80 different proteins during its life cycle. In our latest work ...

2.VCA-IgM：是一种非特异性的诊断指标，在EBV感染初期即可检出，通常持续数周至数月消失，若仍存在则提示可能处于慢性感染状态。 二、特异性IgG 1 ...

Although it is unclear what can trigger a reactivation of EBV, it may be due to an activation of B cells — a type of white blood cells in your immune system — in response to an unrelated ...

A newly identified condition, called “post-vaccination syndrome” (PVS), appears to be linked to mRNA Covid vaccines.

In animal studies, a similar vaccine candidate from ModeX generated neutralising antibodies in mice, ferrets, and nonhuman primates that inhibited EBV entry into both B cells and epithelial cells ...

(Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV ... range of hematological malignancies and B-cell driven autoimmune diseases.

(Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV ... range of hematological malignancies and B-cell driven autoimmune diseases.